Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Therapeutic Category
Antidiabetic, ENDOCRINOLOGY and Hormonal range, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹299/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Emplozin SM 10 Tablet is a combination medication used in the management of Type 2 diabetes mellitus in adults. This tablet combines three active ingredients: Empagliflozin, Sitagliptin, and Metformin, each of which plays a unique role in regulating blood glucose levels.
This combination tablet is intended for patients with Type 2 diabetes who have not achieved adequate blood glucose control with diet and exercise alone or with other oral medications. Emplozin SM 10 Tablet is used to improve glycemic control in combination with a proper diet and exercise regimen.
The synergistic action of these three drugs helps in reducing both fasting and postprandial blood sugar levels, improving overall diabetes management and reducing the risk of complications associated with the disease.
Common side effects may include nausea, headache, abdominal discomfort, and dizziness. Serious side effects may include low blood sugar (especially when combined with other anti-diabetic drugs), lactic acidosis, or kidney problems.
For the treatment of Type 2 diabetes mellitus in adults to improve blood glucose control, in combination with diet and exercise.
Not recommended for patients with severe kidney disease or diabetic ketoacidosis. Regular kidney function monitoring is advised during treatment.
Store at room temperature in a cool, dry place, away from direct sunlight. Keep out of the reach of children.
Composition : Empagliflozin 25mg + Sitagliptin 100mg + Metformin 1000mg (extended release)
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Composition : Empagliflozin (25mg) + Linagliptin (5mg)
Composition : Empagliflozin (10mg) Tablet
Composition : Empagliflozin (12.5mg) + Metformin (1000mg)
Composition : Empagliflozin (12.5mg) + Metformin (500mg)
Composition : Empagliflozin (5mg) + Metformin (500mg)
Composition : Empagliflozin (10mg) + Sitagliptin 100mg
Composition : Empagliflozin (25mg) + Sitagliptin (100mg) Tablet
Composition : Empagliflozin (25mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This advanced triple-combination anti-diabetic formulation is widely used in type 2 diabetes management, making it a high-demand prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, blood sugar control, insulin resistance management, cardiovascular risk reduction support, and long-term glycemic management. The extended-release formulation helps improve patient compliance and is commonly prescribed by diabetologists and physicians for comprehensive diabetes care.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Empagliflozin 10mg + Sitagliptin 100mg + Metformin 1000mg Extended Release Tablets with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from strong chronic prescription demand, growing diabetic patient populations, repeat monthly therapy usage, and high acceptance in diabetology segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.